论文部分内容阅读
为了改进对细菌性痢疾的治疗方法,摸索新的治疗途径,我们遵照卫生部“提倡使用磺胺药物”的指示精神,落实东北五局“三病”防治协作项目,在我院党委的领导下,我科由去年五月份开始用酞磺胺噻唑(PST)和磺胺6甲氧嘧啶(DS-36)与磺胺增效剂甲氧苄胺嘧啶(TMP)合用治疗急性菌痢,现将疗效观察结果总结报告如下: 一、诊断标准以原交通部在柳州召开的“三病”防治会议上制定的“菌痢”诊断标准为准。本报告病例全部符合该项标准。急性典型菌痢:急性发作之腹泻、伴有腹痛、里急后重、脓血便、大便常规镜检白细胞(++)以上、红细胞(++)、脓球(++)、或伴有不
In order to improve the treatment of bacillary dysentery and explore new ways of treatment, we follow the spirit of “Advocating the Use of Sulfa Drugs” issued by the Ministry of Health to implement the “Three Diseases Prevention and Control Project” in Northeast China. Under the leadership of the party committee of our hospital, In May last year, our department started the treatment of acute bacillary dysentery with the combination of sulfometuril (PST) and sulfamethoxine (DS-36) and the sulfonamide synergist trimethoprim (TMP) The report is as follows: I. Diagnostic criteria The diagnostic criteria of “bacillary dysentery” formulated at the “three diseases” prevention and control meeting held by the former Ministry of Transportation in Liuzhou shall prevail. All the reported cases met the criteria. Acute typical bacillary dysentery: acute episode of diarrhea accompanied by abdominal pain, tenesmus, pus and blood stool, conventional stool examination leukocyte (++) or more, erythrocytes (++), pus ball (++)